https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Maternal prenatal stress exposure and sex-specific risk of severe infection in offspring https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45050 Wed 26 Oct 2022 16:03:47 AEDT ]]> Follow up on atopy and the gastrointestinal tract: a review of a common association 2018 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37101 Tue 18 Aug 2020 10:23:42 AEST ]]> Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36101 Thu 17 Feb 2022 09:25:33 AEDT ]]> Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48154 Thu 09 Mar 2023 09:37:46 AEDT ]]> Tangible pathologies in functional dyspepsia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36097 Helicobacter pylori and other pathophysiological changes, most notably duodenal pathology, namely duodenal eosinophilia, permeability alterations, structural neuronal changes and microbial duodenal dysbiosis. This has led to the idea that FD is a true disease entity and triggers of this condition based on epidemiology studies point towards allergy, immune disorders and infection. Anxiety and depression may precede or follow FD, (brain-gut/gut-brain disorders). Currently most therapies for FD are inadequate but underlying pathology may lead to targeted treatment success as an attainable goal.]]> Thu 06 Feb 2020 09:59:06 AEDT ]]> Epigenetic changes in childhood asthma (commentary) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8198 Sat 24 Mar 2018 08:36:19 AEDT ]]> Do sex and atopy influence cough outcome measurements in children? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13277 Sat 24 Mar 2018 08:15:17 AEDT ]]> The overlap of atopy and functional gastrointestinal disorders among 23 471 patients in primary care https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19132 Sat 24 Mar 2018 07:55:53 AEDT ]]> Atopy and the gastrointestinal tract - a review of a common association in unexplained gastrointestinal disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21293 Sat 24 Mar 2018 07:54:36 AEDT ]]> Maternal asthma, breastfeeding, and respiratory outcomes in the first year of life https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40099 χ² tests and logistic regression models, adjusting for confounders, were utilized. Data were complete for 605 participants at T1 and 486 (80%) at T2. Of 605 participants: 89% initiated breastfeeding and 38% breastfed for more than 6 months. Breastfeeding for more than 6 months vs “never” was associated with a reduced adjusted relative risk of infant wheeze at T1 (0.54, 95% confidence interval, 0.30‐0.96). Bronchiolitis risk was reduced at T1 and T2 with more than 6 months of breastfeeding vs “never.” Breastfeeding duration of 1 to 3 months, 4 to 6 months, and more than 6 months were associated with a reduced risk of infant healthcare utilization (all P < .05, vs “never”), but not medication use (P > .05). Breastfeeding for more than 6 months was associated with a reduced risk of wheeze, bronchiolitis, and wheeze‐related healthcare utilization in infants at risk due to maternal asthma. Notably, breastfeeding for shorter durations was associated with a reduced risk of healthcare utilization compared with none. Larger cohorts are needed to further examine the impact of breastfeeding exposure on respiratory health in infants exposed to maternal asthma.]]> Mon 06 May 2024 11:07:39 AEST ]]>